A brief history of medical cannabis in Brazil<\/h2>\n
The use of cannabis as a therapeutic tool has an ancient origin. In Brazil, the first records date back to colonization, with the literature reporting the use of cannabis for medicinal purposes by both African slaves and aristocratic Portuguese. Queen Carlota Joaquina, for example, frequently used cannabis tea to treat migraines and menstrual cramps.<\/p>\n
Brazil had to wait until 2019 for<\/span><\/span>Anvisa (National Health Surveillance Agency)<\/span><\/span><\/a> to finally regulate the procedures for the manufacture and commercialization of cannabis-based products in the country.<\/p>\n The participation of patients and patient\u2019s families was paramount in this legalization dialogue with the public authorities. Below, we outline a brief timeline to understand this journey.<\/p>\n \u00a0<\/p>\n Naturally, the regulation of the medicinal use of cannabis boosts the development of industries and increasing the number of health professionals, entrepreneurs, and researchers in this sector.<\/p>\n Currently, the use of cannabis for medicinal purposes is authorized in more than 40 countries<\/b>, including the United States (US), which for political-economic reasons led the fight against the plant in the previous century.<\/p>\n In 2016, the US invested $6.7 billion<\/b> into this industry, which is estimated to be around $20 billion<\/b> by 2021, according to research conducted by the Arcview Market Research Group, referenced in a report by \u00c9poca Neg\u00f3cios.<\/span><\/span><\/a><\/p>\n In 2018 alone, the global cannabis market handled $12 billion<\/span><\/span><\/a> worldwide.<\/p>\n According to a 2019 report surveyed by Prohibition Partners, a British strategy and intelligence agency dedicated to the global cannabis market, this number is expected to jump to $103.9 billion next year<\/span><\/span><\/a>.<\/p>\n These figures cover all businesses related to legal cannabis, including recreational, industrial, and medical use, and show how promising this market is in the short, medium, and long term.<\/p>\n \u00a0<\/p>\n With the number of patients benefiting from cannabinoid therapy expected to reach 3.9 million in the next three years, data from New Frontier Data’s 2020<\/span> <\/span><\/a> report is very promising from a medicinal perspective.<\/p>\n Some 80,000 cannabis-based products have already been purchased by Brazil since their imports were cleared in 2016.<\/p>\n Although the country’s regional medical councils report the existence of 4,50,000 practicing medical professionals, only 1,100 doctors<\/span><\/span><\/a> (0.2%) are prescribing cannabis-based medicines. This is due to misinformation and, above all, the lack of adequate training in the area, based on scientific evidence and successful practices.<\/p>\n Although the numbers show excellent growth prospects in the global medical cannabis market, specialized training in the field is essential to fully exploit the benefits of cannabinoid therapy through assertive, safe, and effective prescriptions.<\/p>\n WeCann Academy<\/b> aims to assist you in this mission. We connect with experts from all over the world as part of a global community of research and studies on the endocannabinoid system, connecting scientific knowledge and practical experience.<\/p>\n Do you want to take part in this community? Contact us<\/a> and learn more about it!<\/p>\n\n
Global medical cannabis market growth<\/h2>\n
Importance of specialized medical cannabis training<\/h3>\n
![\"\"](\"https:\/\/wecann.academy\/wp-content\/uploads\/2021\/01\/1200175589298646.wQXUtJOh0gDsWkSe2ilY_height640.png\" "\\"\\"")
<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"